4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000899243-23-011292
Chief Development Officer sold 176 shares at $10.22 ($1,799)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Michaelson Jennifer Chief Development Officer | 2023-04-12 | Sale | −176 | $10.22 | $1,799 | 91,117 | D: show line 1 in the form |
| Open-market sales · 176 sh · avg $10.22 · $1,799 | |||||||
Loading xslF345X04/doc4.xml…